Our investor proposition
GSK is a science-led global healthcare company that aims to deliver growth and improving returns to shareholders through the development of innovative pharmaceutical, vaccine and consumer healthcare products.
2018 Third quarter results announcement
On Wednesday 31 October we will announce our third quarter results for the period ended 30 September 2018.
Following the announcement there will be a webcast, hosted by Emma Walmsley, CEO; Simon Dingemans, CFO; Luke Miels, President, Global Pharmaceuticals; and David Redfern, Chief Strategy Officer at 14:30 GMT, 10:30 EDT.